Filing Details

Accession Number:
0001193125-23-279971
Form Type:
13D Filing
Publication Date:
2023-11-19 19:00:00
Filed By:
Perceptive Advisors
Company:
Vbi Vaccines Inc (NASDAQ:VBIV)
Filing Date:
2023-11-20
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Perceptive Advisors 0 1,381,355 0 1,381,355 1,381,355 5.8%
Joseph Edelman 0 1,381,355 0 1,381,355 1,381,355 5.8%
Perceptive Life Sciences Master Fund, Ltd 0 1,381,355 0 1,381,355 1,381,355 5.8%
Perceptive Credit Holdings 0 0 0 0 0 0.0%
Filing

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 13D/A

THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 8)*

 

 

VBI Vaccines Inc.

(Name of Issuer)

Common Shares, no par value per share

(Title of Class of Securities)

91822J 202

(CUSIP Number)

Alexander Rakitin

Perceptive Advisors LLC

51 Astor Place, 10th Floor

New York, NY 10003

(646) 205-5340

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 17, 2023

(Date of Event Which Requires Filing of this Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13D-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box  ☐.

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.

 

 

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 91822J 202

 

  (1)    

  Name of reporting persons

 

  Perceptive Advisors LLC

  (2)  

  Check the appropriate box if a member of a group

  (a)  ☐        (b)  ☒

 

  (3)  

  SEC use only

 

  (4)  

  Source of funds

 

  AF

  (5)  

  Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  (6)  

  Citizenship or place of organization

 

  Delaware

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     (7)     

  Sole voting power

 

  0

     (8)   

  Shared voting power

 

  1,381,355

     (9)   

  Sole dispositive power

 

  0

   (10)   

  Shared dispositive power

 

  1,381,355

(11)    

  Aggregate amount beneficially owned by each reporting person

 

  1,381,355

(12)  

  Check box if the aggregate amount in Row (11) excludes certain shares*

 

  ☐

(13)  

  Percent of class represented by amount in Row (11)

 

  5.8%

(14)  

  Type of reporting person

 

  IA


CUSIP No. 91822J 202

 

  (1)    

  Name of reporting persons

 

  Joseph Edelman

  (2)  

  Check the appropriate box if a member of a group

  (a)  ☐        (b)  ☒

 

  (3)  

  SEC use only

 

  (4)  

  Source of funds

 

  AF

  (5)  

  Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  (6)  

  Citizenship or place of organization

 

  United States of America

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     (7)     

  Sole voting power

 

  0

     (8)   

  Shared voting power

 

  1,381,355

     (9)   

  Sole dispositive power

 

  0

   (10)   

  Shared dispositive power

 

  1,381,355

(11)    

  Aggregate amount beneficially owned by each reporting person

 

  1,381,355

(12)  

  Check box if the aggregate amount in Row (11) excludes certain shares*

 

  ☐

(13)  

  Percent of class represented by amount in Row (11)

 

  5.8%

(14)  

  Type of reporting person

 

  IN


CUSIP No. 91822J 202

 

  (1)    

  Name of reporting persons

 

  Perceptive Life Sciences Master Fund, Ltd.

  (2)  

  Check the appropriate box if a member of a group

  (a)  ☐        (b)  ☒

 

  (3)  

  SEC use only

 

  (4)  

  Source of funds

 

  WC

  (5)  

  Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  (6)  

  Citizenship or place of organization

 

  Cayman Islands

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     (7)     

  Sole voting power

 

  0

     (8)   

  Shared voting power

 

  1,381,355

     (9)   

  Sole dispositive power

 

  0

   (10)   

  Shared dispositive power

 

  1,381,355

(11)    

  Aggregate amount beneficially owned by each reporting person

 

  1,381,355

(12)  

  Check box if the aggregate amount in Row (11) excludes certain shares*

 

  ☐

(13)  

  Percent of class represented by amount in Row (11)

 

  5.8%

(14)  

  Type of reporting person

 

  CO


CUSIP No. 91822J 202

 

  (1)    

  Name of reporting persons

 

  Perceptive Credit Holdings, LP

  (2)  

  Check the appropriate box if a member of a group

  (a)  ☐        (b)  ☐

 

  (3)  

  SEC use only

 

  (4)  

  Source of funds

 

  WC

  (5)  

  Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  (6)  

  Citizenship or place of organization

 

  Delaware

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     (7)     

  Sole voting power

 

  0

     (8)   

  Shared voting power

 

  0

     (9)   

  Sole dispositive power

 

  0

   (10)   

  Shared dispositive power

 

  0

(11)    

  Aggregate amount beneficially owned by each reporting person

 

  0

(12)  

  Check box if the aggregate amount in Row (11) excludes certain shares*

 

  ☐

(13)  

  Percent of class represented by amount in Row (11)

 

  0.0%

(14)  

  Type of reporting person

 

  PN


Item 5. Interest in Securities of the Issuer.

Item 5 of the Schedule 13D is amended and supplemented as follows:

 

  (a)

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 is based on 23,687,695 outstanding Common Shares as reported by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2023, and gives effect to the Issuers 30-to-1 reverse stock split effected on April 12, 2023 (the Reverse Stock Split).

 

  (b)

The information set forth in rows 7 through 10 of the cover pages to this Schedule 13D is incorporated by reference and gives effect to the Reverse Stock Split.


SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

Date:   November 17, 2023
PERCEPTIVE ADVISORS LLC
By:  

/s/ Joseph Edelman

  Name: Joseph Edelman
  Title: Managing Member

/s/ Joseph Edelman

JOSEPH EDELMAN
PERCEPTIVE LIFE SCIENCES MASTER FUND, LTD.
By:   Perceptive Advisors LLC
By:  

/s/ Joseph Edelman

  Name: Joseph Edelman
  Title: Managing Member
PERCEPTIVE CREDIT HOLDINGS, LP
By:   Perceptive Advisors LLC
By:  

/s/ Joseph Edelman

  Name: Joseph Edelman
  Title: Managing Member